Cerebrovascular & Carotid
Artery Disease
Bibliography
- Johnston SC, Gress DR, Browner WS, Sidney S. Short-term
Prognosis After Emergency Department Diagnosis of TIA. JAMA,
2000; 284:2901-2906.
- Goldstein LB, Adams R, Becker K, Furberg
CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ,
Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf
PA, Zoppo GJ. Primary Prevention of Ischemic Stroke. A Statement
for Healthcare Professionals From the Stroke Council of the
American Heart Association. Stroke, 2001; 32:280-299.
- The National Institute of Neurological Disorders and Stroke
rt-PA Stroke Study Group. Tissue Plasminogen Activator for
Acute Ischemic Stroke. The New England
Journal of Medicine,
1995; 333: 1581-1587.
- Marler JR, Tilley BC, Lu M, Brott
TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP,
Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP, for
the NINDS rt-PA Stroke Study Group. Early stroke treatment associated
with better outcome. The NINDS rt-PA Stroke Study. Neurology,
2000; 55:1649-1655.
- Furlan A, Higashida R, Wechsler L, Gent
M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM,
Silver F, Rivera F, for the PROACT Investigators. JAMA, 1999;
282:2003-2011.
- Tomsick T, Brott T, Barsan W, Broderick J,
Haley EC, Spiker J and Khoury J. Prognostic Value of the Hyperdense
Middle Cerebral Artery Sign and Stroke Scale Score before
Ultraearly Thrombolytic Therapy. AJNR, 1996; 17:79-85.
- Connors JJ. Interventional Stroke Therapy: The Potential Benefit
of Direct Intra-Arterial Infusion. XX
- del Zoppo GJ, Higashida
RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, DSc, and the PROACT
Investigators. PROACT: A Phase II Randomized Trial of Recombinant
Pro-Urkinase by Direct Arterial Delivery in Acute Middle Cerebral
Artery Stroke. Stroke, 1998; 29:4-11.
- Albers GW, Bates VE,
Clark WM, Bell R, Verro P, Hamilton SA. Intravenous Tissue-Type
Plasminogen Activator for Treatment of Acute Stroke. The Standard
Treatment with Alteplase to Reverse Stroke (STARS) Study. JAMA,
2000; 283:1145-1150.
- Wang DZ, Rose JA, Honings DS, Garwacki
DJ, Milbrandt JC, for the OSF Stroke Team. Treating Acute Stroke
Patients with Intravenous tPA. The OSF Stroke Network Experience.
Stroke, 2000; 31:77-81.
- Lenzer J. Alteplase for stroke:
money and optimistic claims buttress the "brain attack" campaign.
BMJ, 2002; 324: 723-729.
- Lenzer J, Warlow C, Saver JL,
Kidwell CS, Starkman S. Alteplase for stroke: money and optimistic
claims buttress the "brain
attack" campaign. Commentary: Who
pays the guideline writers?. Commentary:
Thrombolysis in stroke: it works! XX
- Hill MD, Barber PA, Demchuk AM, Newcommon
NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button
A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick
RJ, Buchan AM. Acute Intravenous-Intra-Arterial
Revascularization Therapy for Sever Ischemic
Stroke. Stroke, 2002; 33:279-282.
- Counsell C, Sandercock P. Low-Molecular-Weight
Heparins or Heparinoids Versus Standard Unfranctionated
Heparin for Acute Ischemic Stroke (Chochrane Review). Stroke,
2002; 33:1925-1926.
- Moonis M, Fisher M. Considering
the Role of Heparin and Low-Molecular-Weight Heparins in Acute
Ischemic Stroke. Stroke, 2002: 33: 1927-1933.
- Coull BM,
Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi
S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL,
Levine SR, Saver JL. Anticoagulants and Antiplatelet Agents in
Acute Ischemic Stroke. Report of the Joint Stroke Guideline Development
Committee of the American Academy of Neurology and the American
Stroke Association (a Division of the American Heart Association).
Stroke, 2002; 33:1934-1942.
- Adams HP. Emergent Use of
Anticoagulation for Treatment of Patients With Ischemic Stroke.
Stroke, 2002; 33:856-861.
- Muir KW, Roberts M. Thrombolytic
Therapy for Stroke. A Review with Particular Reference to Elderly
Patients. Drugs & Aging,
2000; January:41-54
- Coull
BM, Williams LS, Goldstein LB, Meschia JF, Heitzman
D, Chaturvedi S, Johnston KC,
Starkman S, Morgenstern LB,
Wilterdink JL, Levine SR, Saver
JL. Anticoagulants and Antiplatelet
Agents in Acute Ischemic Stroke.
Report of the Joint Stroke
Guideline Development Committee
of the American Academy of Neurology
and the American Stroke Association (a
Division of the American Heart Association).
Stroke, 2002; 33:1934-1942.
- McNamara R. AAEM Position Statement of the
Use of Intravenous Thromblytic Therapy in the Treatment
of Stroke. XX
- Uraneck K. ACEP Crafts tPA For Stroke Policy.
Emergency Medicine Community Divided Over Drug’s
Use. XX
- The American College of Emergency Physicians
(ACEP). Use of Intravenous tPA for the Management
of Acute Stroke in the Emergency Department. XX
- The CAEP Committee on Thrombolytic
Thearpy for Acute Ischemic Stroke. Position Statement
on Thrombolytic Therapy for Acute Ischemic Stroke. XX
- Higashida R, Connors
JJ. Should Interventional Radiologists Be Involved in Acute
Stroke Intervention? Re: Emergency Interventional Stroke Therapy:
A Statement from the American Society of Interventional and Therapeutic
Neuroradiology and the Society of Cardiovascular & Interventional
Radiology. SCVIR,
2001; February:145-146.
- Connors JJ, Wojak
JC. Percutaneous transluminal
angioplasty for intracranial
atherosclerotic lesions: evolution of technique
and short-term results. J. Neurosurg, 1999;
91:415-422.
- Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine
SR, Silliman S, Pessin
MS, Weichel E, Sila CA, Furlan AJ, Kargman DE, Sacco RL, Wityk RJ, Ford
G, Fayad PB, for the Warfarin-Aspirin Symptomatic Intracranial
Disease Study Group. The Warfarin-Aspirin
Symptomatic Intracranial Disease Study. Neurology, 1995: 45: 1488-1493.
- Connors
JJ, Wojack JC. Intracranial Angioplasty. The Journal of Invasive
Cardiology, 1998; 10:298-303.
- Thija VN, Albers GW. Symptomatic
intracranial atherosclerosis. Outcome of patients who
fail antithrombotic therapy. Neurology, 2000; 55:1-x.
- The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID)
Study Group. Prognosis of Patients With Symptomatic Vertebral
or Basilar Artery Stenosis. Stroke, 1998; 29:1389-1392.
- Chaloupka JC, Weigele JB, Mangla S, Lesley WS. Cerebrovascular
Angioplasty and Stenting for the Prevention of Stroke. Current
Neurology and Neuroscience Reports, 2001; 1:39-53.
- The
EC/IC Bypass Study Group. Failure of Extracranial;-Intracranial
Arterial Bypass to Reduce the Risk of Ischemic Stroke.
Results of an International Randomized Trial. The
New England Journal of Medicine, 1985; 313:1191-1199.
- Guthikonda M, Guyot LL,
Diaz FG. Future of extracranial-intracranial bypass. Neurological
Research, 2002; 24:S80-S83.
- Gomez CR, Misra VK, Liu MW,
Wadlington VR, Terry JB, Tulyapronchote R, Campbell MS.
Elective Stention of Symptomatic Basilar Artery
Stenosis. Stoke, 2000; 31:95-99.
- Sacco RL, Elkind MS. Update
on Antiplatelet Therapy for Stroke Prevention. Arch
Intern Med, 2000; 160: 1579-1582.
- Kaplan ED, Sacco RL. Selection
of Anticoagulants or Antiplatelet-aggregating Agents for Prevention
of Stroke. Current Neurology and Neuroscience
Reports, 2002;
2:31-37.
- Alexander G, Turpie G. Successors to heparin: New
antihrombotic agents. American Heart Journal,
1997; 134:S71-S77.
- Albers GW, Amarenco P, Easton JD,
Sacco RL, Teal P. Antithrombotic and
Thrombolytic Therapy for Ischemic Stroke.
Chest, 2001; 119: 300S-320S.
- Gorelick PB.
Stroke Prevention Therapy Beyond Antithrombotics: Unifying
Mechanisms in Ischemic Stroke Pathogenesis and Implications
for Therapy. An Invited Review. Stroke, 2002;
33:862-875.
- Selnes OA, McKhann GM. Coronary-Artery
Bypass Surgery and the Brain. The New
England Journal of Medicine, 2001; 334:451-452.
- Newman MF, Kirchner JL, Phillips-Bute
B, Gaver V, Grocott H, Jones RH, Mark DB, Reves
JG, Blumenthal JA, for the Neurological Outcome Research Group and the
Cardiothoracic Anesthesiology Research Endeavors
Investigators. The New England Journal of Medicine, 2001; 344: 395-402.
- Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann
SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong
Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF, Smith
SC, Stone NJ, Taubert KA. AHA Guidelines for Primary Prevention
of Cardiovascular Disease and Stroke: 2002 Update.
Consensus Panel Guide to Comprehensive Risk Reduction
for Adult Patients Without Coronary or Other Atherosclerotic
Vascular Diseases. Circulation, 2002; 106:388-391.
- Cundiff DK. Thrombolysis for Acute Myocardial Infarction:
Drug Review. XX
- Patrono C, Coller B, Dalen JE, Dalen JE,
Fitzgerald GA, Fuster V, Gent M, Hirsh J, Roth G. Platelet-Active
Drugs. The Relationships Among Dose, Effectiveness,
and Side Effects. Chest, 2000; 119:39S-63S.
- Hirsh
J, Anand SS, Halperin JL, Fuster V. Guide to Anticoagulant
Therapy: Heparin. A Statement for Healthcare Professionals From
the American Heart Association. Circulation, 2000; 103:2994-3018.
- Hirsh
J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke
R, Granger C, Ohman EM, Dalen JE. Heparin and Low-Molecular-Weight
Heparin. Mechanisms of Acton, Pharmacokinetics, Dosing, Monitoring,
Efficacy, and Safety. Chest, 2001; 119:64S-94S.
- Adams HP,
Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason
CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M,
Ex Officio Members. Guidelines for the Management of Patients
With Acute Ischemic Stroke. A Statement for Healthcare Professional
From a Special Writing Group of the Stroke Council, American
Heart Association. Stroke, 1994; 25:1901-1914.
- Adams
HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski
T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Theis
W, Ex Officio Members. Guidelines for Thrombolytic Therapy
for Acute Stroke: A Supplement to the Guidelines for the Management
of Patients With Acute Ischemic Stroke. A Statement for Healthcare
Professionals From a Special Writing Group of
the Stroke Council, American Heart Association.
XX
- Culebras A, Kase CS, Masdeu JC, Fox AJ, Bryan RN, Grossman
B, Lee DH, Adams HP, Thies W, Ex
Officio Members. Practice Guidelines for the Use of Imaging in
Transient Ischemic Attacks and Acute Stroke. A Report of
the Stroke Council, American Heart Association. XX
- Albers GW, Hart RG,
Lutsep HL, Newell DW, Sacco RL. Supplement to the Guidelines
for the Management of Transient Ischemic Attacks. A Statement
From the Ad Hoc Committee on Guidelines for the Management
of Transient Ischemic Attacks, Stroke Council, American
Heart Association. Stroke, 1999: 30:2502-2511.
- Mayberg MR, Batjer
HH, Dacey R, Diringer M, Haley C, Heros RC, Sernau LS, Torner
J, Adams HP, Feinberg W, Theis W, Ex Officio Members. Guidelines
for the Management of Aneurysmal Subarachnoid Hemorrhage.
A Statement for Healthcare Professionals From a Special Writing
Group of the Stroke Council, American Heart Association.
- Broderick JP, Adams HP, Barsan W, Feinberg W, Feldmann E,
Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM,
Zuccarello M. Guidelines for the Management of Spontaneous Intracerebral
Hemorrhage. A Statement for Healthcare Professionals From a
Special Writing Group of the Stroke Council, American Heart
Association. Stroke, 1999; 30:905-915.
- Wolf PA, Clagett GP, Easton D, Goldstein
LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP.
Preventing Ischemic Stroke in Patients With Prior Stroke and Transient
Ischemic Attack. A Statement for Healthcare
Professionals From the Stroke Council of the American Heart
Association. Stroke, 1999; 30:1991-1994.
- Kelly-Hayes M, Robertson JT,
Broderick JP, Duncan PW, Hershey LA, Roth EJ, Thies WH, Trombly
CA. The American Heart Association Stroke Outcome
Classification. Stroke, 1998; 29:1274-1280.
- Rodriquez DV.
Cerebrovascular Occlusions. XX
- Brott T, Bogousslavsky J.
Treatment of Acute Ischemic Stroke. The
New England Journal of Medicine, 2000; 343:710-722.
- Mohr JP, Thompson JLP,
Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW,
Pettigrew LC, Adams HP, Jackson CM, Pullicino P, for the
Warfarin-Aspirin Recurrent Stroke Study Group. A Comparison
of Warfarin and Aspirin for the Prevention of Recurrent
Ischemic Stroke. The New England
Journal of Medicine,
2001; 345:1444-1451.
- Mohr JP, Thompson JLP,
Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW,
Pettigrew LC, Adams HP, Jackson CM, Pullicino P, for the
Warfarin-Aspirin Recurrent Stroke Study Group.
A Comparison of Warfarin and Aspirin for the
Prevention of Recurrent Ischemic Stroke. The
New England Journal of Medicine, 2001; 345: 1444-1451.
|